Related Experiment Videos
Who should receive antiendotoxin monoclonal antibody therapy?
Clinical Pharmacy
|March 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2003
Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.
Clinical transplantation·2001
Renal transplant patient compliance with free immunosuppressive medications.
Transplantation·2000
Trends in antifungal research.
EXS·2000
Assistance programs available for medications commonly used in transplant patients.
Clinical transplantation·2000
Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic.
Clinical transplantation·2000
Efficacy of nutritional supplements used by athletes.
Clinical pharmacy·1993
Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
Clinical pharmacy·1993
Sotalol: a new class III antiarrhythmic agent.
Clinical pharmacy·1993
Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
Clinical pharmacy·1993
Pathophysiology of septic shock and implications for therapy.
Clinical pharmacy·1993
Cladribine for the treatment of hematologic malignancies.
Clinical pharmacy·1993
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.
The Journal of experimental medicine·2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.
Molecular cancer therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.
Molecular pharmaceutics·2026